{"id":15481,"date":"2026-02-13T16:23:30","date_gmt":"2026-02-13T15:23:30","guid":{"rendered":"https:\/\/www.cbd.fr\/blog\/?p=15481"},"modified":"2026-02-13T16:23:32","modified_gmt":"2026-02-13T15:23:32","slug":"cbd-and-european-regulations-what-will-change-in-2025","status":"publish","type":"post","link":"https:\/\/www.cbd.fr\/blog\/en\/cbd-and-european-regulations-what-will-change-in-2025\/","title":{"rendered":"CBD and European regulations: what will change in 2025"},"content":{"rendered":"

The entire European CBD landscape has been undergoing profound transformation in recent years. Major adjustments are affecting everything from agricultural production and the sale of CBD products to their legal status as therapeutic substances. The year 2025 is shaping up to be crucial with the entry into force of new directives within the European Union, marking a turning point for industry players and consumers. It is therefore essential to understand how European legislation is evolving, as well as the alignment between France and the European Union, and the main changes concerning the permitted THC<\/a> levels, authorized hemp varieties, and the regulations governing the medical and recreational uses of cannabidiol. The Foundations of the New CBD Regulations<\/strong> The year 2025 marks a pivotal moment in the evolution of the legal framework for CBD. For some time now, the European Commission has been multiplying its initiatives to harmonize CBD regulations across its various member states. Until now, each country still had significant room for interpretation, generating commercial uncertainty and legal insecurity surrounding the marketing of CBD. This trend will now diminish thanks to more unified European legislation. The objectives are clear: to guarantee consumer safety, support the hemp industry, and avoid any risk of confusion with traditional recreational cannabis. To consult the detailed evolution of the regulations and clarify the issue of the maximum permitted concentration, you can refer to the legislation on CBD in France and the European Union. Towards a common definition of CBD and medical cannabis: A central point of this evolution concerns the clear distinction between medical or therapeutic cannabis and products containing only CBD extracted from industrial hemp. This regulatory clarification should prevent cannabidiol from being wrongly associated with illicit drugs.<\/strong> The future directive therefore proposes a harmonized list of hemp varieties authorized in Europe and precisely defines their medical or wellness uses. This recognition will foster trust among practitioners and patients, as well as specialized distributors.<\/strong> Standardization of manufacturing and marketing standards The unification of practices is also reflected in the standardization of manufacturing processes, traceability, and labeling for all CBD products intended for the European market. This includes dried flowers, oils, cosmetics, and hemp-derived food supplements.<\/strong> Precise labeling of the permitted THC level will become mandatory on all packaging from 2025; this single threshold will replace the multiple national values \u200b\u200bpreviously observed. Furthermore, increased controls by health authorities will help to effectively limit the risks of fraud or misinformation to consumers. Permitted THC Levels and Hemp Varieties: What Adjustments Are Needed?<\/strong> The permitted THC level is often the cornerstone of CBD regulation in Europe.<\/strong> In 2025, EU legislation will establish a uniform maximum threshold across the entire territory: it will be set at 0.3% THC, in all forms. This criterion aims to guarantee the low psychoactive effect of hemp products and to facilitate their intra-European circulation. It should be noted that this rule stems from the recognition of CBD as a legal product within the European Union when it complies with this threshold, as defined in the European regulations on maximum THC content.<\/strong> The adoption of this standard addresses the need to provide greater legal certainty.<\/strong>while boosting the competitiveness of the European sector in the face of increasingly dynamic international markets. Impact on producers and variety selection<\/strong> A direct consequence of the<\/p>\n\n

\n
\n

Sommaire<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n